Transcriptomics

Dataset Information

0

RNA-seq profiles between human parental and 5-FU drug resistant HCT116 and SW480 colorectal cancer cell lines


ABSTRACT: Colorectal cancer (CRC) is one of the most frequently diagnosed and lethal malignancy. Several key factors including poor dietary habits, smoking, alcohol consumption, genetic predisposition, obesity, diabetes mellitus, and sedentary lifestyle – all result in a significantly increased risk for developing CRC. Current treatment modalities for patients with CRC include surgery, which is often followed with adjuvant chemotherapy, especially in patients with a stage II and III disease. Most patients with advanced CRC are generally treated with the chemotherapeutic drug, 5-fluorouracil (5-FU) – either given alone or in combination with oxaliplatin and other molecularly-targeted drugs. While such treatment regimens are effective at improving disease outcomes, their clinical usefulness is often hampered due to the considerable toxicity associated with these treatments, which often causes severe nausea, vomiting, weight loss, and risk of infectious complications due to immunosuppression. Furthermore, their therapeutic efficacy is limited due to the emergence of chemotherapeutic drug resistance. In this study we performed genomewide transcriptomic analysis of parental and 5-FU resistant cells to identify differentially expressed genes and its associated pathways in promoting chemoresistance in CRC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE196900 | GEO | 2022/02/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-08-05 | GSE181537 | GEO
| EGAS00001003592 | EGA
2020-12-30 | GSE89531 | GEO
| PRJNA756936 | ENA
2022-01-21 | GSE193865 | GEO
2021-02-10 | GSE157950 | GEO
2021-02-10 | GSE157949 | GEO
| PRJNA797915 | ENA
2015-06-03 | GSE69494 | GEO
2023-12-01 | GSE219171 | GEO